Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study.
Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study. Cancer Treat Rep. 1979 Feb; 63(2):319-23.